Blockchain Registration Transaction Record

UK Study Finds Way to Stop Lung Cancer Before Diagnosis

UK study finds clearing immune fog may stop lung cancer early. Calidi Biotherapeutics advances immunotherapies for cancer interception. Read more on BioMedWire.

This news matters because it highlights a paradigm shift in oncology toward cancer interception, where treatments aim to halt malignancies before they become life-threatening. Such early interventions could lead to more effective and less toxic therapies, improving survival rates and quality of life for patients. The involvement of companies like Calidi Biotherapeutics underscores the growing commercial interest in advanced immunotherapies that may complement existing approaches. As research progresses, these breakthroughs could transform cancer care from reactive treatment to proactive prevention, ultimately reducing the global cancer burden.